Cyclophosphamide,Doxorubicin,Vincristine,Prednisone
not tagged
['ptcl', 'lymsm', ' ipi ']
pragmatic mutation-adapted rct of various x-chop regimens in ptcl #17icml
- 96 pts (80% adv stage, 88% ipi 2+, most aitl)
- sig better cr &amp; pfs with xchop; no diff in os
- better cr in tet2 &amp; tp53 muts
impressive, bold study design. benefit appears to be driven by aitl. #lymsm 
Lymphoma doc & patient-reported outcomes researcher in #lymsm and #mmsm @CUHematology. Founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. 🏳️‍🌈